ストックスクリーナーアプリを入手
3.75
5.54%
-0.22
アフターアワーズ：
3.75
Xeris Biopharma Holdings Inc (XERS) 最新ニュース
Who Really Controls Xeris Biopharma? The Retail Investors’ Unseen Power - DSA
Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) top owners are retail investors with 50% stake, while 45% is held by institutions - Yahoo Finance
Xeris Biopharma (NASDAQ:XERS) Hits New 12-Month High – Still a Buy? - Defense World
Xeris Biopharma (NASDAQ:XERS) Hits New 12-Month HighStill a Buy? - MarketBeat
Xeris Pharmaceuticals stock hits 52-week high of $3.87 - Investing.com India
Xeris Pharmaceuticals stock hits 52-week high of $3.87 By Investing.com - Investing.com South Africa
Legato Capital Management LLC Purchases Shares of 142,164 Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - MarketBeat
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Stake Raised by Janney Montgomery Scott LLC - Defense World
Take off with Xeris Biopharma Holdings Inc (XERS): Get ready for trading - SETE News
Xeris Biopharma Holdings Inc [XERS] Shares Fall -1.36 % on Thursday - Knox Daily
Omnicell, Inc [OMCL] Records 50-Day SMA of $44.59 - Knox Daily
Stock Performance Spotlight: Xeris Biopharma Holdings Inc (XERS) Ends the Day at 3.64, Up by 1.39 - The Dwinnex
Xeris to Participate in Upcoming Investor Conferences - BioSpace
A year in review: Xeris Biopharma Holdings Inc (XERS)’s performance in the last year - US Post News
SG Americas Securities LLC Raises Stock Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Perhaps timely catching Xeris Biopharma Holdings Inc (XERS) would be a good idea - SETE News
Piper Sandler downgrades Xeris Biopharma Holdings Inc (XERS) rating to a Neutral - Knox Daily
Some Shareholders Feeling Restless Over Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) P/S Ratio - Simply Wall St
JPMorgan Chase & Co. Acquires 67,557 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Xeris Biopharma Holdings Inc (NASDAQ: XERS) Down -1.47% This Year: What To Expect Next - Stocks Register
The American Diabetes Association and Xeris Pharmaceuticals Announce National Collaboration to Provide Life-Saving Hypoglycemia Education and Awareness - Beloit Daily News
ADA Partners With Xeris to Combat Rising Diabetes Emergency Cases Amid 202,000 Annual ER Visits - StockTitan
Xeris Biopharma Holdings Inc (XERS) With A Potential Upside Of More Than -103.7% - Stocks Register
Barclays PLC Boosts Stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Xeris Biopharma raises FY24 revenue view to $203M from $198M-$202M - MSN
Arecor stock plummets after Tetris retreat - Business Weekly
Xeris Biopharma (NASDAQ:XERS) Stock Price Up 5.7%Here's Why - MarketBeat
Xeris Expects to Exceed Full-Year 2024 Financial Guidance - BioSpace
Xeris Biopharma exceeds 2024 revenue guidance - Investing.com India
Xeris Biopharma Exceeds 2024 Guidance with $203M Revenue, Posts Record Q4 Growth - StockTitan
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Stock Position Lifted by Principal Financial Group Inc. - Defense World
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)January 6, 2025 - BioSpace
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Shares Acquired by Geode Capital Management LLC - Defense World
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Shares Sold by Jane Street Group LLC - Defense World
Barclays PLC Purchases 151,685 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - MarketBeat
State Street Corp Sells 53,915 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Applied Therapeutics Appoints John H. Johnson as Executive Chairman - The Manila Times
Xeris Biopharma (NASDAQ:XERS) Shares Up 5.2%What's Next? - MarketBeat
Quantbot Technologies LP Purchases Shares of 15,425 Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Walleye Capital LLC Purchases Shares of 1,121,738 Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Invests $237,000 in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
XERS (Xeris Biopharma Holdings) Revenue : $187.4 Mil (TTM As of Sep. 2024) - GuruFocus.com
Xeris Biopharma Holdings (FRA:2B30) Other Long Term Assets : €4.9 Mil (As of Sep. 2024) - GuruFocus.com
XERS (Xeris Biopharma Holdings) Other Stockholders Equity : $0.0 Mil (As of Sep. 2024) - GuruFocus.com
XERS (Xeris Biopharma Holdings) EPS (Diluted) : $-0.44 (TTM As of Sep. 2024) - GuruFocus.com
XERS (Xeris Biopharma Holdings) GF Score : 75/100 (As of Nov. 26, 2024) - GuruFocus.com
XERS (Xeris Biopharma Holdings) Accounts Payable : $7.5 Mil (As of Sep. 2024) - GuruFocus.com
GSA Capital Partners LLP Sells 578,313 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference - Business Wire
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):